Saved in:
| Main Authors: | Liam Mannion, Verity Watson, Vinod Mullassery, Rajesh Nair, Thomas Charlton, Margaret Northover, Deborah Enting, Mieke Van Hemelrijck, Muhammad Shamim Khan, Ramesh Thurairaja, Suzanne Amery, Kathryn Chatterton, Kate Smith, Simon Hughes |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2024
|
| Subjects: | |
| Online Access: | https://bjui-journals.onlinelibrary.wiley.com/doi/10.1002/bco2.443 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Understanding oncological and sexual function outcomes with gynaecological organ preserving cystectomy in women with bladder cancer; a systematic review
by: Rebecca Martin, et al.
Published: (2025)
by: Rebecca Martin, et al.
Published: (2025)
Perioperative chemotherapy use and related outcomes in muscle‐invasive bladder cancer in Australia
by: Alison Hiong, et al.
Published: (2025)
by: Alison Hiong, et al.
Published: (2025)
Haematuria cancer risk score as a predictor of muscle‐invasive bladder cancer
by: Serdar Turan, et al.
Published: (2025)
by: Serdar Turan, et al.
Published: (2025)
Predictors of adherence to surveillance cystoscopy for patients with non‐muscle invasive bladder cancer
by: Katherina Y. Chen, et al.
Published: (2026)
by: Katherina Y. Chen, et al.
Published: (2026)
Novel neoadjuvant therapies for muscle‐invasive bladder cancer: Systematic review and meta‐analysis
by: Shugo Yajima, et al.
Published: (2025)
by: Shugo Yajima, et al.
Published: (2025)
Reduced p63 expression is linked to unfavourable prognosis in muscle‐invasive urothelial carcinoma of the bladder
by: Kira Furlano, et al.
Published: (2024)
by: Kira Furlano, et al.
Published: (2024)
Lymph node dissection during cystectomy for non‐muscle‐invasive bladder cancer: A systematic review
by: Sean Lim, et al.
Published: (2026)
by: Sean Lim, et al.
Published: (2026)
Time toxicity of intravesical BCG versus sequential intravesical gemcitabine and docetaxel for non‐muscle‐invasive bladder cancer
by: Jacob Hanna, et al.
Published: (2026)
by: Jacob Hanna, et al.
Published: (2026)
Long non‐coding RNAs define favourable biology in high‐risk non‐muscle‐invasive bladder cancer
by: Rachel Weng, et al.
Published: (2025)
by: Rachel Weng, et al.
Published: (2025)
Long‐term outcome of transurethral laser ablation for recurrent non‐muscle invasive bladder cancer: An EORTC risk‐matched study
by: Chase Peng Yun Ng, et al.
Published: (2025)
by: Chase Peng Yun Ng, et al.
Published: (2025)
A systematic review of the patient reported outcomes that affect patients with muscle invasive bladder cancer after radical cystectomy and urinary diversion
by: John Lahoud, et al.
Published: (2024)
by: John Lahoud, et al.
Published: (2024)
Real‐world use of maintenance bacillus Calmette‐Guérin therapy in patients with non‐muscle‐invasive bladder cancer in Japan: ASUKA study
by: Makito Miyake, et al.
Published: (2025)
by: Makito Miyake, et al.
Published: (2025)
Real‐world oncological and toxicity outcomes with the Moscow strain of intravesical BCG for non‐muscle invasive bladder cancer—Implications for global shortage
by: Amandeep Arora, et al.
Published: (2025)
by: Amandeep Arora, et al.
Published: (2025)
Intravesical gemcitabine and docetaxel vs. re‐induction Bacillus Calmette Guerin as first‐line salvage therapy for non‐muscle invasive bladder cancer
by: Kylie Yen‐Yi Lim, et al.
Published: (2025)
by: Kylie Yen‐Yi Lim, et al.
Published: (2025)
Understanding the long‐term impact of the COVID‐19 pandemic on non‐muscle‐invasive bladder cancer outcomes: 12‐Month follow‐up data from the international, prospective COVIDSurg Cancer study
by: Cameron E. Alexander, et al.
Published: (2024)
by: Cameron E. Alexander, et al.
Published: (2024)
Outcomes of Aquablation in BPH with bladder stones: Analysis of the ICARUS database
by: Joshua D. Cabral, et al.
Published: (2026)
by: Joshua D. Cabral, et al.
Published: (2026)
Patient experience of bladder cancer: A data linkage study
by: Snehadhar Shah, et al.
Published: (2024)
by: Snehadhar Shah, et al.
Published: (2024)
Health utility value of overactive bladder in Japanese older adults
by: Takashi Yoshioka, et al.
Published: (2024)
by: Takashi Yoshioka, et al.
Published: (2024)
Acu‐URO17 is a highly sensitive and specific bladder cancer biomarker
by: Liwu Guo, et al.
Published: (2024)
by: Liwu Guo, et al.
Published: (2024)
Comparison of staging MRI to re‐resection for localised bladder cancer: Narrative review
by: Hugo Klempfner, et al.
Published: (2024)
by: Hugo Klempfner, et al.
Published: (2024)
Understanding symptom contribution to sex inequality in bladder and renal cancer stage at diagnosis
by: Yin Zhou, et al.
Published: (2024)
by: Yin Zhou, et al.
Published: (2024)
Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
by: Arjun Pon Avudaiappan, et al.
Published: (2024)
by: Arjun Pon Avudaiappan, et al.
Published: (2024)
Impact of pre‐stenting and bladder dranaige on intrapelvic pressure during retrograde intrarenal surgery
by: Sezgin Yeni, et al.
Published: (2025)
by: Sezgin Yeni, et al.
Published: (2025)
Preoperative FAN score predicts survival outcomes after radical cystectomy for bladder cancer
by: Yu Ishizuya, et al.
Published: (2026)
by: Yu Ishizuya, et al.
Published: (2026)
Germline homologous recombination repair (gHRR) variants in bladder cancer: Preliminary evidence and clinical implications
by: Rodolfo Hurle, et al.
Published: (2025)
by: Rodolfo Hurle, et al.
Published: (2025)
The potential role of precision medicine to alleviate racial disparities in prostate, bladder and renal urological cancer care
by: Kunal K. Sindhu, et al.
Published: (2024)
by: Kunal K. Sindhu, et al.
Published: (2024)
Comparing fluorodeoxyglucose positron emission tomography with computed tomography in staging for nodal and distant metastasis in urothelial/bladder cancer
by: Mohammed Al‐Zubaidi, et al.
Published: (2024)
by: Mohammed Al‐Zubaidi, et al.
Published: (2024)
Long‐term follow‐up of intradetrusor botulinum toxin utilisation: A comparison of patients with multiple sclerosis and idiopathic overactive bladder
by: William Chui, et al.
Published: (2024)
by: William Chui, et al.
Published: (2024)
Does bladder outflow obstruction obfuscate the traditional clinical factors that are used to assess the risk of prostate cancer at rapid‐access diagnostic clinics?
by: Thomas Philip Cahill, et al.
Published: (2024)
by: Thomas Philip Cahill, et al.
Published: (2024)
Muscle matters: Skeletal muscle index and body mass index impact on complications and survival in renal cancer
by: Alexander Hintze Hillers, et al.
Published: (2024)
by: Alexander Hintze Hillers, et al.
Published: (2024)
Single‐port robot‐assisted ureterolysis for retroperitoneal fibrosis: A less invasive path to functional recovery
by: Filippo Carletti, et al.
Published: (2026)
by: Filippo Carletti, et al.
Published: (2026)
Quantification of perineural invasion on prostate biopsy improves risk stratification in biopsy Grade Group 2–3 cancer
by: Yuki Teramoto, et al.
Published: (2026)
by: Yuki Teramoto, et al.
Published: (2026)
Preoperative pelvic floor muscle diameter as a predictor of postoperative urinary incontinence in robotic‐assisted laparoscopic total prostatectomy
by: Sho Hashimoto, et al.
Published: (2025)
by: Sho Hashimoto, et al.
Published: (2025)
Early oncological outcomes of delayed radical prostatectomy: A prospective, international, follow‐up analysis of the COVIDSurg‐Cancer study
by: Arjun Nathan, et al.
Published: (2024)
by: Arjun Nathan, et al.
Published: (2024)
Targeting genomic receptors in voided urine for confirmation of benign prostatic hyperplasia
by: Mathew Thakur, et al.
Published: (2024)
by: Mathew Thakur, et al.
Published: (2024)
Giant testicular germ‐cell tumours—An analysis of relative incidence and clinical features based on a clinical case series and a survey of the literature
by: Markus Angerer, et al.
Published: (2026)
by: Markus Angerer, et al.
Published: (2026)
Prognostic factors and treatment impact on overall survival in patients with renal neuroendocrine tumour
by: Olamide O. Omidele, et al.
Published: (2024)
by: Olamide O. Omidele, et al.
Published: (2024)
Recurrence patterns following nephrectomy for renal cell carcinoma in a Danish nationwide cohort
by: Goran Bencina, et al.
Published: (2024)
by: Goran Bencina, et al.
Published: (2024)
Prevention of lymphoceles using peritoneal flaps during robotic‐assisted radical prostatectomy with pelvic lymph node dissection: A systematic review and meta‐analysis
by: Huseyin Yildiz, et al.
Published: (2026)
by: Huseyin Yildiz, et al.
Published: (2026)
Treatment decision regret after precision prostatectomy: An analysis of patient‐reported outcomes predicting decision regret
by: Kaushik P. Kolanukuduru, et al.
Published: (2024)
by: Kaushik P. Kolanukuduru, et al.
Published: (2024)
Similar Items
-
Understanding oncological and sexual function outcomes with gynaecological organ preserving cystectomy in women with bladder cancer; a systematic review
by: Rebecca Martin, et al.
Published: (2025) -
Perioperative chemotherapy use and related outcomes in muscle‐invasive bladder cancer in Australia
by: Alison Hiong, et al.
Published: (2025) -
Haematuria cancer risk score as a predictor of muscle‐invasive bladder cancer
by: Serdar Turan, et al.
Published: (2025) -
Predictors of adherence to surveillance cystoscopy for patients with non‐muscle invasive bladder cancer
by: Katherina Y. Chen, et al.
Published: (2026) -
Novel neoadjuvant therapies for muscle‐invasive bladder cancer: Systematic review and meta‐analysis
by: Shugo Yajima, et al.
Published: (2025)